MEF2C ameliorates learning, memory, and molecular pathological changes in Alzheimer’s disease in vivo and<?A3B2 ACK?>in vitro
Myocyte enhancer factor 2C (MEF2C) is highly expressed in the nervous system, and regulates neuro-development, synaptic plasticity, and inflammation. However, its mechanism in Alzheimer’s disease (AD) is underestimated. In this study, the role and mechanism of MEF2C were investigated in the brain ti...
Main Authors: | Ren Jiamou, Zhang Shuli, Wang Xiaoling, Deng Yuxin, Zhao Yi, Xiao Yan, Liu Jian, Chu Liangzhao, Qi Xiaolan |
---|---|
Format: | Article |
Language: | English |
Published: |
China Science Publishing & Media Ltd.
2021-12-01
|
Series: | Acta Biochimica et Biophysica Sinica |
Subjects: | |
Online Access: | https://www.sciengine.com/doi/10.3724/abbs.2021012 |
Similar Items
-
Isoform Specific Effects of Mef2C during Direct Cardiac Reprogramming
by: Li Wang, et al.
Published: (2020-01-01) -
<i>mef2ca</i> and <i>mef2cb</i> Double Mutant Zebrafish Show Altered Craniofacial Phenotype and Motor Behaviour
by: Andreia Adrião, et al.
Published: (2023-05-01) -
Activin A Causes Muscle Atrophy through MEF2C-Dependent Impaired Myogenesis
by: Audrey Loumaye, et al.
Published: (2022-03-01) -
Mapk7 deletion in chondrocytes causes vertebral defects by reducing MEF2C/PTEN/AKT signaling
by: Chengzhi Wu, et al.
Published: (2024-03-01) -
Orchestration of Genetic Alterations in <i>PSEN1</i> and <i>PSEN2</i> Genes in Development of Alzheimer's Disease through Computational Analysis
by: Asif Mir, et al.
Published: (2024-01-01)